Life cycle approaches in the pharmaceutical and healthcare sector

In the last year, many pharmaceutical companies have made bold sustainability commitments, including net zero targets. This presentation gives on overview of the drivers behind the sector’s interest in LCA and carbon footprinting. It provides examples of where the environmental hotspots are typically found in pharmaceutical and healthcare products, highlights the challenges LCA practitioners face when conducting assessments in this industry, and presents a case study from one of ERM’s pharmaceutical clients.